Rascas 1.5mg Injection
By Rascas
Rx
1 Injection in a Vial

Composition
Rasburicase(1.5mg)

Manufacturer - Sayre Therapeutics Pvt Ltd
91, 3rd Floor, G. R. Square, Amarjyothi Nagar HBCS Layout, Inner Ring Road, Domlur, Bangalore 560071, Karnataka, India.

Expires on or after
September, 2025

liver
Rascas 1.5mg Injection is considered generally safe for individuals with liver disease, based on the limited data currently available. It is likely that adjusting the dose of Rascas 1.5mg Injection may not be necessary for patients with liver conditions. However, it is crucial to consult with your doctor before using this medication to ensure it is suitable for your specific liver health situation.

kidney
Rascas 1.5mg Injection is considered safe for patients with kidney disease. Available data indicates that dosage adjustment may not be necessary in these cases. Consult your doctor for personalized advice.

alcohol
Consult your doctor when consuming alcohol with Rascas 1.5mg Injection.

driving
It is unclear if Rascas 1.5mg Injection affects driving ability. Avoid driving if you have symptoms impacting focus and reaction time.

pregnancy
Rascas 1.5mg Injection may not be safe during pregnancy. Limited human studies suggest potential harm to the developing baby. Consult your doctor to evaluate benefits and risks before use.

breastfeeding
Rascas 1.5mg Injection is considered safe for use during breastfeeding, based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Recombinant Xanthine Oxidase Enzyme |
Therapeutic Class | - |
Action Class | Uricolytic agent- Chemotherapy |
₹10560
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024